Navigation Links
Director of Proteomics at the Broad Institute of MIT and Harvard, Steven Carr, to Deliver Pittcon 2014 Wallace H. Coulter Plenary Lecture
Date:5/15/2013

Pittsburgh, PA (PRWEB) May 15, 2013

Dr. Carr is internationally recognized as a leader in the development of novel proteomics methods and in their application in biology and medicine. Dr. Carr and his group collaborate with scientists throughout the greater Broad community (Broad Institute, Harvard, Harvard Medical School, and the 17 Harvard affiliated hospitals) to apply state-of-the art proteomics technology to address compelling questions in biology, chemistry and clinical medicine. He has over 200 publications on development and use of proteomics and biological mass spectrometry.

Carr’s lecture will address the new era of quantitative biology enabled by mass spectrometry based proteomic technologies that has arrived. The content, relative abundance, modification states and interaction partners of proteins in a dynamic and temporal manner on a near-global basis in organelles, whole cells and clinical samples, providing information of unprecedented detail can now be defined. At the Broad Institute, Carr and his team are employing these technologies in a wide array of studies including delineating the genetic underpinnings of mitochondrial disorders, connecting cancer genotype to molecular phenotype, unraveling the basis of the innate-immune response, identifying the mechanism of action of drug-like molecules and to discover and verify protein biomarkers of disease. A representative set of project vignettes will be presented to convey a sense of the breadth and depth of application of modern proteomics to biology and medicine.

When asked to comment on his work, Dr. Carr stated, "Significant improvements in mass spectrometry-based proteomic technologies over the past few years have greatly increased the value and necessity of analyzing proteins and their modifications in biology and medicine. The number of proteins observed in cells and tissues now begins to approximate the expected expressed proteome.” H
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2

Related biology technology :

1. Intra-Cellular Therapies Appoints Professor Sir Michael Rawlins to its Board of Directors
2. Avenida Suites Hires Director for Global Business Development
3. Ohr Pharmaceutical Appoints Thomas M. Riedhammer To Board Of Directors
4. Darpa Director Shares Vision of a New Generation of Technology and Commercial Applications at SPIE Defense, Security, and Sensing
5. Henri A. Termeer Joins Moderna Therapeutics Board Of Directors
6. David Hooper Joins Evolution Marketing Research as Senior Director, Research
7. Exosome Diagnostics Names Kapil Dhingra Chairman of the Board of Directors
8. Orexigen CEO Michael Narachi Elected to PhRMA Board of Directors
9. Jerry Adams Joins VIC Technology Venture Development Board of Directors
10. Roberto DellOro Named Director of LMUs Bioethics Institute
11. California Healthcare Institute Appoints Associate Director, Federal Government Relations and Programs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/2/2014)... The National Institutes of Health (NIH) ... today to develop an electrode array system that ... brain works through unprecedented resolution and scale. , ... to support President Obama's BRAIN (Brain Research through ... to revolutionize our understanding of the human mind ...
(Date:10/2/2014)... 2014  CSSi ( www.CSSiEnroll.com ), the leader ... industry, is pleased to announce its participation in ... October.  President Chris Trizna will be ... Clinical Trials New England conference sponsored by Arena ... annual Site Solutions Summit sponsored by the Society ...
(Date:10/2/2014)... India , October 2, 2014 ... showcased its biometrics capabilities at the prestigious Annual Conference ... in Las Vegas , where they ... presented on varied topics like ,data analytics to support ... / registry studies, and ,benefits of working together as ...
(Date:10/1/2014)... Oct. 1, 2014  Discovery Laboratories, Inc. (Nasdaq: ... awarded a Phase II Small Business Innovation Research ... from the National Institute of Allergy and Infectious ... (NIH) to support the development of the Company,s ... countermeasure to mitigate acute and chronic/late-phase radiation-induced lung ...
Breaking Biology Technology:NIH taps Lawrence Livermore to Develop Sophisticated Electrode Array System to Monitor Brain Activity 2NIH taps Lawrence Livermore to Develop Sophisticated Electrode Array System to Monitor Brain Activity 3NIH taps Lawrence Livermore to Develop Sophisticated Electrode Array System to Monitor Brain Activity 4Patient Recruitment Expert CSSi to be Featured at Upcoming Industry Events 2Patient Recruitment Expert CSSi to be Featured at Upcoming Industry Events 3SIRO Clinpharm Showcases Biometrics Capabilities at the SCDM 2014 Annual Conference in Las Vegas 2Discovery Labs Receives SBIR Grant Valued up to $3.0 Million to Support Development of Aerosolized KL4 Surfactant to Address Radiation-Induced Lung Injury 2Discovery Labs Receives SBIR Grant Valued up to $3.0 Million to Support Development of Aerosolized KL4 Surfactant to Address Radiation-Induced Lung Injury 3
... SEATTLE, March 8, 2011 Cell Therapeutics, Inc. (CTI) ... present at the Bio Europe Spring 2011 Conference on ... 1, room Yellow 2, at Milano Convention Centre, Milan, ... PM CET /10:30 AM EST/ 7.30 AM PSTRoom Yellow ...
... NEW YORK, March 7, 2011 Reportlinker.com ... is available in its catalogue: ... strategic assessment of the competitive environment is ... priority management responsibilities, the task crucial to ...
... Reportlinker.com announces that a new market ... The 2011 Blood Banking ... and Business Expansion Strategies for Suppliers ... During the next ten years, the blood ...
Cached Biology Technology:Reportlinker Adds The 2011 Top Ten World's Leading Life Science Intermediates Companies 2Reportlinker Adds The 2011 Blood Banking Market: US, Europe, Japan - Emerging Opportunities and Business Expansion Strategies for Suppliers 2
(Date:9/30/2014)... engineers, led by Clemson University associate professor Brian ... from the U.S. Department of Energy,s Experimental Program ... positive impact on South Carolina in the advancement ... , "Understanding the scientific and engineering needs for ... nuclear technologies is imperative if South Carolina is ...
(Date:9/30/2014)... and farm runoff in Hawaii is causing tumors in ... The study, published Tuesday in the peer-reviewed open-access journal ... ends up in algae that the turtles eat, promoting ... and internal organs. , Scientists at Duke University, the ... Administration (NOAA) conducted the study to better understand the ...
(Date:9/30/2014)... available in German . ... response to risky situations such as exposure to predators. ... found in a long-term study on different populations of ... rate and ambient temperature. High metabolic rates and low ... these scenarios birds were more likely to approach potential ...
Breaking Biology News(10 mins):Researchers get $5.25 million to advance nuclear technologies in South Carolina 2Pollution linked to lethal sea turtle tumors 2Pollution linked to lethal sea turtle tumors 3Risky metabolism 2
... Despite dozens of interceptions at U.S. ports, a public enemy ... N.Y., and identified by a Cornell University expert, the adult ... discovered in the eastern United States. , The discovery of ... woodwasp, raises red flags across the nation because the invasive ...
... study in the April issue (currently available online) ... take scientists closer to understanding how cells in ... Researchers, led by Anthony Firulli, Ph.D., associate professor ... at the Indiana University School of Medicine, investigated ...
... to happen - you being in a car wreck or being ... greater killers win a free trip to the beach. It's really ... being in a wreck are far greater than being a shark's ... who has studied sharks for years. , Worldwide, about one million ...
Cached Biology News:Alien woodwasp, threat to US pine trees, found in N.Y. 2Determining The Fate Of Cells In The Human Body 2New HIV drug candidate developed in Sweden 2